#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema Alagille syndrome Nephroblastoma Acute myeloid leukaemia recurrent Cutaneous T-cell lymphoma stage I Oesophageal squamous cell carcinoma stage II Von Hippel-Lindau disease Metastases to central nervous system Deafness neurosensory Restless legs syndrome Spinal cord injury Short stature homeobox gene mutation Biliary cancer metastatic Pleomorphic liposarcoma Polymyositis More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Diagnostics Marginal zone lymphoma – Trials in Disease Acute respiratory distress syndrome – Life with Disease Mantle cell lymphoma – Basic Information Hyperoxaluria Castleman’s disease – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Mucopolysaccharidosis III – Treatment Amyotrophic lateral sclerosis – Life with Disease Encephalitis autoimmune – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eik1003 GSKVX000000070965 Hypothalamic Phospholipids 534 Oxaliplatin Sodium Nitroprusside Dihydrate Vericiguat Fluoroethyltyrosine F-18 A52 Methotrexate Disodium Petosemtamab Bexotegrast Digoxin Ampicillin Pasireotide Diaspartate Etifoxine Hydrochloride Palonosetron Histamine Hydrochloride ZIRCONIUM (89ZR) GIRENTUXIMAB Bisoprolol Fumarate More therapies…

    Learn about Your Condition

    Dry eye Sickle cell disease Vulvovaginal dryness Perineal injury Invasive breast carcinoma Palmoplantar pustulosis Gastrectomy Anogenital warts Desmoid tumour B-cell lymphoma refractory Ear discomfort Psychogenic seizure Netherton's syndrome Tympanic membrane perforation Abdominal wall pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Coma

  • Study of anti-seizure drug combination in comatose patients with status epilepticus after cardiac arrest

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lacosamide
    • Levetiracetam
    • Diazepam
    Belgium The Netherlands

  • Study on the Effects of Sodium Lactate and Electrolyte Solution in Comatose Patients After Cardiac Arrest

    Recruiting

    2 1 1
    Investigated Diseases:
    • Post cardiac arrest syndrome
    • Reperfusion injury
    • Coma
    Investigated Drugs:
    • Sodium Lactate
    • Sodium Gluconate
    • Sodium Acetate Trihydrate
    Belgium

  • Study on Apomorphine and Psilocybin for Recovery in Coma Patients with Acute Brain Injury

    Recruiting

    1 1 1
    Investigated Diseases:
    • Coma
    Investigated Drugs:
    • Apomorphine Hydrochloride Hemihydrate
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    • Sodium Chloride
    Denmark

  • Study to evaluate the effect of methylphenidate hydrochloride on the time to wake up in patients in a coma due to acute brain injury

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Coma
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Austria Denmark France Germany

  • Study on Psilocybin and Apomorphine for Improving Consciousness in Patients with Coma and Brain Injury

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Coma
    Investigated Drugs:
    • Apomorphine Hydrochloride Hemihydrate
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    • Sodium Chloride
    Denmark

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!